First Time Loading...

Fuji Pharma Co Ltd
TSE:4554

Watchlist Manager
Fuji Pharma Co Ltd Logo
Fuji Pharma Co Ltd
TSE:4554
Watchlist
Price: 1 552 JPY 0.58% Market Closed
Updated: Apr 29, 2024

Fuji Pharma Co Ltd
Operating Income

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Fuji Pharma Co Ltd
Operating Income Peer Comparison

Comparables:
4502
4568
4578
4519
4503

Competitive Operating Income Analysis
Latest Figures & CAGR of Competitors

Company Operating Income CAGR 3Y CAGR 5Y CAGR 10Y
Fuji Pharma Co Ltd
TSE:4554
Operating Income
¥2.5B
CAGR 3-Years
-13%
CAGR 5-Years
-10%
CAGR 10-Years
-2%
Takeda Pharmaceutical Co Ltd
TSE:4502
Operating Income
¥464.9B
CAGR 3-Years
7%
CAGR 5-Years
18%
CAGR 10-Years
17%
Daiichi Sankyo Co Ltd
TSE:4568
Operating Income
¥188B
CAGR 3-Years
37%
CAGR 5-Years
19%
CAGR 10-Years
5%
Otsuka Holdings Co Ltd
TSE:4578
Operating Income
¥294.7B
CAGR 3-Years
13%
CAGR 5-Years
32%
CAGR 10-Years
3%
Chugai Pharmaceutical Co Ltd
TSE:4519
Operating Income
¥444.2B
CAGR 3-Years
14%
CAGR 5-Years
29%
CAGR 10-Years
19%
Astellas Pharma Inc
TSE:4503
Operating Income
¥142B
CAGR 3-Years
-5%
CAGR 5-Years
-12%
CAGR 10-Years
3%

See Also

What is Fuji Pharma Co Ltd's Operating Income?
Operating Income
2.5B JPY

Based on the financial report for Dec 31, 2023, Fuji Pharma Co Ltd's Operating Income amounts to 2.5B JPY.

What is Fuji Pharma Co Ltd's Operating Income growth rate?
Operating Income CAGR 10Y
-2%

Over the last year, the Operating Income growth was -26%. The average annual Operating Income growth rates for Fuji Pharma Co Ltd have been -13% over the past three years , -10% over the past five years , and -2% over the past ten years .